Hims & Hers Health Inc. (HIMS)
Hims & Hers Health Statistics
Share Statistics
Hims & Hers Health has 213.79M shares outstanding. The number of shares has increased by 2.05% in one year.
| Shares Outstanding | 213.79M |
| Shares Change (YoY) | 2.05% |
| Shares Change (QoQ) | 0.98% |
| Owned by Institutions (%) | 75.75% |
| Shares Floating | 181.97M |
| Failed to Deliver (FTD) Shares | 92 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 56.58M, so 26.93% of the outstanding shares have been sold short.
| Short Interest | 56.58M |
| Short % of Shares Out | 26.93% |
| Short % of Float | 31.87% |
| Short Ratio (days to cover) | 5.02 |
Valuation Ratios
The PE ratio is 41.43 and the forward PE ratio is 32.18. Hims & Hers Health's PEG ratio is -0.07.
| PE Ratio | 41.43 |
| Forward PE | 32.18 |
| PS Ratio | 3.54 |
| Forward PS | 1.4 |
| PB Ratio | 10.95 |
| P/FCF Ratio | 24.93 |
| PEG Ratio | -0.07 |
Enterprise Valuation
Hims & Hers Health Inc. has an Enterprise Value (EV) of 1.78B.
| EV / Earnings | 14.09 |
| EV / Sales | 1.2 |
| EV / EBITDA | 28.7 |
| EV / EBIT | 28.7 |
| EV / FCF | 8.48 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.79 |
| Quick Ratio | 1.5 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.32 |
| Cash Flow / Debt | 22.13 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.26% and return on capital (ROIC) is 22.29%.
| Return on Equity (ROE) | 0.26% |
| Return on Assets (ROA) | 0.18% |
| Return on Capital (ROIC) | 22.29% |
| Revenue Per Employee | $901,963.35 |
| Profits Per Employee | $76,993.28 |
| Employee Count | 1,637 |
| Asset Turnover | 2.09 |
| Inventory Turnover | 4.71 |
Taxes
| Income Tax | -54.33M |
| Effective Tax Rate | -0.76 |
Stock Price Statistics
The stock price has increased by 106.27% in the last 52 weeks. The beta is 1.37, so Hims & Hers Health's price volatility has been higher than the market average.
| Beta | 1.37 |
| 52-Week Price Change | 106.27% |
| 50-Day Moving Average | 39.21 |
| 200-Day Moving Average | 26.09 |
| Relative Strength Index (RSI) | 41.92 |
| Average Volume (20 Days) | 22.15M |
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 1.48B and earned 126.04M in profits. Earnings per share was 0.58.
| Revenue | 1.48B |
| Gross Profit | 1.17B |
| Operating Income | 61.9M |
| Net Income | 126.04M |
| EBITDA | 61.9M |
| EBIT | 61.9M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 220.58M in cash and 11.35M in debt, giving a net cash position of 209.24M.
| Cash & Cash Equivalents | 220.58M |
| Total Debt | 11.35M |
| Net Cash | 209.24M |
| Retained Earnings | -242.14M |
| Total Assets | 707.54M |
| Working Capital | 174.46M |
Cash Flow
In the last 12 months, operating cash flow was 251.08M and capital expenditures -41.66M, giving a free cash flow of 209.43M.
| Operating Cash Flow | 251.08M |
| Capital Expenditures | -41.66M |
| Free Cash Flow | 209.43M |
| FCF Per Share | 0.97 |
Margins
Gross margin is 79.45%, with operating and profit margins of 4.19% and 8.54%.
| Gross Margin | 79.45% |
| Operating Margin | 4.19% |
| Pretax Margin | 4.86% |
| Profit Margin | 8.54% |
| EBITDA Margin | 4.19% |
| EBIT Margin | 4.19% |
| FCF Margin | 14.18% |
Dividends & Yields
HIMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.82% |
| FCF Yield | 3.07% |
Analyst Forecast
The average price target for HIMS is $35, which is 9.7% higher than the current price. The consensus rating is "Hold".
| Price Target | $35 |
| Price Target Difference | 9.7% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 22.35 |
| Piotroski F-Score | 5 |